Dr. Jogender Tushir-Singh

Conference abstract

The functional crosstalk between tissue transglutaminase (TG2) and CD24 enhances cancer stem cell traits and therapy resistance in high grade serous ovarian cancer

Primary record (external link)

Research summary

This 2026 AACR conference abstract reports preclinical work on tissue transglutaminase (TG2)–CD24 crosstalk, ovarian cancer stem-cell traits and treatment resistance. The abstract describes cell and xenograft experiments; a full peer-reviewed article is not linked here.

Authors

Rohit Pravin Nagare, Habeebunnisa Begum, Ben Wamba, Jogender Tushir-Singh, Fabrizio Pin, Salvatore Condello

Cite this work

Rohit Pravin Nagare, Habeebunnisa Begum, Ben Wamba, Jogender Tushir-Singh, Fabrizio Pin, Salvatore Condello (2026). The functional crosstalk between tissue transglutaminase (TG2) and CD24 enhances cancer stem cell traits and therapy resistance in high grade serous ovarian cancer. Cancer Research, AACR Annual Meeting Supplement, 86(7 Supplement), Abstract 831.